
PersonGen BioTherapeutics (Suzhou)Co., Ltd.
Suzhou, China en.persongen.com From their website, Nov 2026
- ISO 9001
Work here? Claim this listing
About
PersonGen BioTherapeutics (Suzhou) Co., Ltd. develops cellular therapeutics, including CAR-T and allogeneic cell therapies, for malignant tumors and autoimmune diseases. Its subsidiary PersonGen.Anke Cellular Therapeutics Co., Ltd. serves as the manufacturing base for clinical-grade cellular products, DNA plasmids, and lentiviruses. The company is based in Suzhou, China, with a manufacturing site in Hefei, Anhui, China.
PersonGen BioTherapeutics (Suzhou)Co., Ltd. is based in Suzhou, China, founded in 2010. It lists 8 services, including CAR-T cell therapy development, Allogeneic cellular therapy development and CAR-related therapeutic and analytical antibody development. It names ISO 9001 on its listing.
Services
CAR-T cell therapy development
Develops CAR-T products for T cell malignancies and other cancers.
Allogeneic cellular therapy development
Develops allogeneic cellular therapies, including off-the-shelf UCAR-Vδ1 T-cell products.
CAR-related therapeutic and analytical antibody development
Develops therapeutic and analytical antibodies related to CAR programs.
Clinical-grade DNA plasmid manufacturing
Manufactures clinical-grade DNA plasmids at its manufacturing base.
Clinical-grade lentivirus manufacturing
Manufactures clinical-grade lentiviruses at its manufacturing base.
CAR-T functional testing
Performs functional testing for CAR-T research and development.
In vivo efficacy verification
Carries out in vivo efficacy verification for cellular therapy candidates.
Bispecific antibody development
Develops bispecific antibody therapeutics through the NanoBa platform.
How to order from PersonGen BioTherapeutics (Suzhou)Co., Ltd.
They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- Cell therapy
- Antibodies
- Lentivirus
- In vivo
- Bispecifics
- Antigen binding domain development
4 more
- CAR structure optimization
- CAR-T functional testing
- In vivo efficacy verification
- Structure and function verification
- Therapeutic areas
- Malignant tumors
- T cell malignancies
- Autoimmune diseases
- Solid tumors
Instruments and platforms
- Most advanced and comprehensive instruments
Modalities and species
- Modalities
- Antibody
- Bispecific
- Viral vector
- Cell therapy
- Plasmid DNA
- Species and models
- Human T cells
- Human NK cells
- Healthy donor peripheral blood
- Quiescent human T cells
- T-cell tumors
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
Details
- Founded
- 2010
- Team
- More than 80% of the R&D scientists have doctoral or master degrees
- Office
- 99 Kongquetai Rd. Build. B2, Hefei High Tech Park, Hefei, Anhui, China Support:
- Sites
- Hefei, China
- Serves
- China